Johnson & Johnson applies for emergency use authorization for COVID-19 vaccine
Johnson & Johnson on Thursday applied for emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine.
This is a single-dose vaccine that can be stored in a refrigerator. If approved, it will be the third coronavirus vaccine authorized for emergency use in the U.S., after the Pfizer/BioNTech and Moderna products.
Last week, Johnson & Johnson said its vaccine is 66 percent effective against moderate to severe infections, while offering protection against hospitalization and death. It is less effective against the COVID-19 variant first discovered in South Africa.
The FDA will now review the company's submission, and an authorization could come sometime in the next few weeks, Politico reports.
More stories from theweek.com
5 brutally funny cartoons about America's bungled vaccine rollout
The growing white supremacist threat
Republicans have lost their grip on the national discourse
